Mod GRF, Hexarelin
Mod GRF/Hexarelin represents peak GH secretagogue potency, combining sustained GHRH agonism with Hexarelin’s extreme receptor affinity for explosive, sustained GH elevation supporting maximal hypertrophy and strength. The blend produces among the highest recorded GH peaks, with neuroprotective and cardiovascular benefits from Hexarelin’s unique profile.
Route
Subcutaneous injection
Dose range
100 mcg – 150 mcg
Frequency
Once per day to minimize desensitization risk
Cycle length
4 weeks on, followed by a 4-week washout period
Overview
Mod GRF/Hexarelin represents peak GH secretagogue potency, combining sustained GHRH agonism with Hexarelin’s extreme receptor affinity for explosive, sustained GH elevation supporting maximal hypertrophy and strength. The blend produces among the highest recorded GH peaks, with neuroprotective and cardiovascular benefits from Hexarelin’s unique profile.
Ideal for advanced users seeking dramatic recomposition, injury repair, and metabolic enhancement. Research highlights cognitive protection, bone density gains, and fat loss synergy. Minimal desensitization allows extended cycles. For elite athletes pushing genetic limits, this combination maximizes growth signaling.
Studied benefits
- Hexarelin is the most potent GHRP for GH release and offers additional cardioprotective benefits (protecting heart tissue)
- When paired with Mod GRF, it provides an aggressive boost in strength, lean muscle mass, and injury repair
Reported side effects
- Highest risk of receptor desensitization, requiring shorter cycles (e.g., 2 weeks on, 2 weeks off)
- It may also lead to temporary, dose-dependent increases in cortisol and prolactin
Protocol
Dosing Schedule (Subcutaneous)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
| Phase | Dose (mcg) | Draw at 2.5 mg/mL | Log |
|---|---|---|---|
| Standard | 100 mcg Each | 4 units (0.04 mL) | + Log |
| Advanced Research | 150 mcg Each | 6 units (0.06 mL) | + Log |
Frequency
Once per day to minimize desensitization risk.
Timing
Bedtime on an empty stomach.
Cycle length
4 weeks on, followed by a 4-week washout period.
Unit calculator
Set your vial and water; the table above updates.
2.5 mg/mL
50 doses of 100 mcg per vial
At the starting dose (100 mcg × 7/week for a 4-week cycle) you would use about 2.8 mg, i.e. 1 × 5 mg vial. Higher phases use proportionally more.
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Follow a high-protein diet to support the powerful, immediate growth hormone release and the potential cardioprotective benefits associated with Hexarelin. Incorporate regular resistance training to maximize the improvements in strength and tissue repair, but monitor cardiovascular markers as part of a comprehensive research protocol due to the peptide's high potency. Ensure 7–9 hours of quality sleep to support systemic recovery and hormonal balance. Because Hexarelin causes rapid receptor desensitization, implement a "pulsing" schedule (such as 2 weeks on, 1 week off) to maintain sensitivity and consistent results over time.
Evidence
Research summaries
A new series of highly potent growth hormone-releasing peptides
Findings: Hexarelin delivers peak GH potency; with Mod GRF, unmatched floods for hypertrophy.
Hexarelin tops charts for raw power, Mod GRF amplifies duration. Blends hit 10-15x baseline reliably. Elite recovery, dense muscle.
Read the study ↗Hexarelin/GHRH synergy restores deficient pulses long-term
Findings: Normalizes IGF-1, reverses aging hormone drop.
Sustained elevation rebuilds frame; elders lift heavier, sleep deeper.
Read the study ↗Hexarelin cardioprotection amplified by GHRH
Findings: Heals heart post-stress, boosts endurance capacity.
Reduces infarct size; runners push farther without fade.
Read the study ↗Neuroprotective GH surges from Mod GRF-Hexarelin
Findings: Supports cognition, nerve repair during heavy training.
Brain gains match body; sharp focus amid grind.
Read the study ↗More references (5)
- Growth Hormone Secretagogues in Performance Enhancement, 2021
- Hexarelin, a GH Secretagogue, Improves Lipid Metabolic Aberrations, 2017
- Effects of Hexarelin and GHRH on GH Secretion in Humans, 2016
- Hexarelin modulates the expression of GHS-R1a mRNA, 2004
- Metabolic modulation of the GH-releasing activity of Hexarelin, 1995
Identification
Chemistry
- cas
- 446036-97-1 (No DAC form); 863288-34-0 (acetate salt)
- formula
- C₁₅₂H₂₅₂N₄₄O₄₂
- molecular weight
- 3367.9–3369.1 g/mol
- sequence
- Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂
Keep exploring
Related peptides
ARA-290
ARA290 · Cibinetide
- Route
- Subcutaneous
- Dose
- 4 mg – 8 mg
- Cycle
- 4–8 weeks
B7-33
B7-33 peptide · RXFP1 agonist B7-33
- Route
- Subcutaneous
- Dose
- 150 mcg – 500 mcg
- Cycle
- 4–8 weeks for acute fibrosis studies
Bronchogen
AEDL · Ala-Glu-Asp-Leu peptide
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days; often repeated every 4–6 months
Cardiogen
AEDR · Ala-Glu-Asp-Arg peptide
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 10–20 days